Modern Pediatrics.Ukraine.2020.1(106):25-32; doi 10.15574/SP.2020.106.25
Marunchyn T., Volokha A.
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

For citation: Marunchyn T, Volokha A. (2020). Clinical and immunological characteristics of children with primary hypogammaglobulinemiae. Modern Pediatrics. Ukraine. 2(106): 25-32. doi 10.15574/SP.2020.106.25
Article received: Nov 27, 2019. Accepted for publication: Mar 04, 2020.

Objective: study of clinical and immunological indicators in children with primary hypogammaglobulinemia in order to determine treatment tactics.
Material and methods. 53 children with primary hypogammaglobulinemiae were examined. Anamnesis and data of immunological examination (levels of serum immunoglobulins IgA, IgM, IgG, subpopulations of lymphocytes) were collected from each child at the time before the beginning of immunoglobulin replacement therapy.
Results. The most common features of primary hypogammaglobulinemia were recurrent bacterial infections, observed in 44 children out of 53 (83%). Autoimmune diseases and allergic diseases were foundwith the same frequency, in 8 children (15.1%). Bronchoectatic disease occurred in 5 children (9.4%). The levels of serum IgG (1.77±2.61 g/l) and IgM (0.062±0.14 g/l), and level of B lymphocytes (0.27±0.22%, 13.7±14.1×10⁹) were the lowest in the group of children with X-linked hypogammaglobulinemia, compared to other groups of children with primary hypogammaglobulinemia.
Conclusions. Therefore, in our study it was found that the most common clinical manifestations in children with primary hypogammaglobulinemia were recurrent bacterial infections, autoimmune and allergic pathology was rare. The development of bronchiectatic disease is associated with the presence of chronic bronchitis and recurrent pneumonia, late diagnosis of antibody deficiency and late beginning of regular immunoglobulin replacement therapy. Early diagnosis and timely correction of antibody deficiency play a key role in the prevention of the development of of bacterial infections and their complications.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of an participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
Key words: primary hypohammaglobulinemia, children, bacterial infections, chronic bronchitis, serum immunoglobulins, subpopulations of lymphocytes, bronchiectasis.

REFERENCES

1. Volokha AP. (2009). Features of the course of primary antibody deficiencies in children, determination of early criteria of diagnostics and rationale of differentiated approaches to treatment. Dissertation. Kyiv: Ministry of Health of Ukraine, National O. O. Bohomolets Medical University:

42.

2. Alkan G, Keles S and Reisli E. (2018, April 23). Evaluation of Clinical and Immunological Characteristics of Children with Common Variable Immunodeficiency. International Journal of Pediatrics. Article ID 3527480: 1–8. https://doi.org/10.1155/2018/3527480; PMid:29849668 PMCid:PMC5937368

3. Azizi G, Ahmadi M, Abolhassani H, Yazdani R et al. (2016). Autoimmunity in Primary Antibody Deficiencies. Int Arch Allergy Immunol.171(3–4): 180–193. https://doi.org/10.1159/000453263; PMid:28013299

4. Azizi G, Bagheri Y, Tavakol M, Askarimoghaddam F et al. (2018). The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies. Endocr Metab Immune Disord Drug Targets.18(5): 537–545. https://doi.org/10.2174/1871530318666180413110216; PMid:29651973

5. Bazregari S, Azizi G, Tavakol M, Asgardoon MH et al. (2017, Dec 30). Evaluation of infectious and non8infectious complications in patients with primary Immunodeficiency. Central European Journal of Immunology. 42(4): 336–341. https://doi.org/10.5114/ceji.2017.72825; PMid:29479289 PMCid:PMC5820987

6. Bonagura V, Kaplan B, Jongco A. (2016). Management of primary antibody deficiency syndromes. Ann Allergy Asthma Immunol.117: 620–626. https://doi.org/10.1016/j.anai.2016.08.016; PMid:27979019

7. Brignier AC, Mahlaoui N, Reimann C, Picard C et al. (2015, Oct). Early-onset hypogammaglobulinemia: A survey of 44 patients. J Allergy Clin Immunol. 136(4): 1097–1099. https://doi.org/10.1016/j.jaci.2015.03.038; PMid:25959671

8. Carvalho PD, Costa C, Rodrigues M, Salvador MJ et al. (2016, Jan-Mar). Dermatomyositis-like syndrome in X-linked agammaglobulinemia. Acta Reumatol Port. 41(1): 78–81.

9. Dorna MB, Santos CJ, Castro AP, Oliveira LA et al. (2016, Sep). Primary hypogammaglobulinemia: The impact of early diagnosis in lung complications. Scielo. 62(6): 530–536. https://doi.org/10.1590/1806-9282.62.06.530; PMid:27849230

10. Fried AJ, Bonilla FA. (2009, July). Pathogenesis, Diagnosis, and Management of Primary Antibody Deficiencies and Infections. Clinical microbiology reviews. 22(3): 396–414. https://doi.org/10.1128/CMR.00001-09; PMid:19597006 PMCid:PMC2708392

11. Janssen LMA, Bassett P, Macken T, van Esch J et al. (2018, Oct 15). Mild Hypogammaglobulinemia Can Be a Serious Condition. Frontiers in immunology. Original Research. 9 (article 2384): 1–8. https://doi.org/10.3389/fimmu.2018.02384; PMid:30374358 PMCid:PMC6196282

12. Kidon MI, Handzel ZT, Schwartz R, Altboum I et al. (2004, Oct 21). Symptomatic hypogammaglobulinemia in infancy and childhood – clinical outcome and in vitro immune responses. BMC Family Practice.5(23): 1–7. https://doi.org/10.1186/1471-2296-5-23; PMid:15498106 PMCid:PMC529469

13. Liu X1, Zhou K, Yu D, Cai X et al. (2017, Dec). A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child. Medicine (Baltimore).96(49): 1–6. https://doi.org/10.1097/MD.0000000000008989; PMid:29245273 PMCid:PMC5728888

14. Lopez-Rocha E, O'Farril-Romanillos P, Cerda-Reyes S, Medina-Torres EA et al. (2017, Apr-Jun). Angioedema as initial manifestation of hypogammaglobulinemia.64(2): 228–234. https://doi.org/10.29262/ram.v64i2.187; PMid:28658731

15. Membrila-Mondragon J, Staines-Boone AT, Sanchez-Sanchez LM, Ruiz-Pedraza MD. (2015). Pulmonary complications in pediatric patients with primary immnodefficiency. Gaceta Medica De Mexico.151: 145–151.

16. Modell V, Knaus M, Modell F, Roifman C et al. (2014, Oct). Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 60(1): 132–44. https://doi.org/10.1007/s12026-014-8498-z; PMid:24668296

17. Tan Q, Ren FL, Wang H. (2017, Aug). Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia. Ann Dermatol.29(4): 476–478. https://doi.org/10.5021/ad.2017.29.4.476; PMid:28761297 PMCid:PMC5500714

18. Tarzi MD, Grigoriadou S, Carr SB, Kuitert LM et al. (2009, Feb). Clinical Immunology Review Series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunology.155(2): 147–155. https://doi.org/10.1111/j.1365-2249.2008.03851.x; PMid:19128358 PMCid:PMC2675244

19. Tavakol M, Kouhi A, Abolhassani H, Ghajar A et al. (2014 Jun). Otological Findings in Pediatric Patients with Hypogammaglobulinemia. Iran J Allergy Asthma Immunol. 13(3): 166–173.